Skip to main content
Fig. 1 | BMC Pediatrics

Fig. 1

From: Effectiveness of BNT162b2 COVID-19 primary series vaccination in children aged 5–17 years in the United States: a cohort study

Fig. 1

Cumulative Incidence of COVID-19 Outcomes in Children Receiving a Primary Series of BNT162b2 and Unvaccinated Comparators. (A). Optum, Medically Diagnosed COVID-19. (B). Optum, Hospital/ED–diagnosed COVID-19. (C). CVS Health, Medically Diagnosed COVID-19. (D). CVS Health, Hospital/ED–diagnosed COVID-19. COVID-19 = coronavirus disease 2019; ED = emergency department.

Back to article page

BMC Pediatrics

ISSN: 1471-2431

Contact us